These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6604899)

  • 1. Schistosoma mansoni: complement activation in human and rodent sera by living parasites of various developmental stages.
    Ruppel A; Rother U; Vongerichten H; Diesfeld HJ
    Parasitology; 1983 Aug; 87 (Pt 1)():75-86. PubMed ID: 6604899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent binding and activation of complement by Schistosoma mansoni adult worms.
    Linder E; Huldt G
    Parasite Immunol; 1983 Mar; 5(2):183-94. PubMed ID: 6601790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
    Santoro F; Lachmann PJ; Capron A; Capron M
    J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-Specific Serum Factors Control the Development and Survival of
    Anisuzzaman ; Frahm S; Prodjinotho UF; Bhattacharjee S; Verschoor A; Prazeres da Costa C
    Front Immunol; 2021; 12():635622. PubMed ID: 33968028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: escape from complement-mediated parasiticidal mechanisms following percutaneous primary infection.
    Ruppel A; McLaren DJ; Diesfeld HJ; Rother U
    Eur J Immunol; 1984 Aug; 14(8):702-8. PubMed ID: 6468491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
    Ouaissi MA; Auriault C; Santoro F; Capron A
    J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni: surface membrane stability in vitro and in vivo.
    Ruppel A; McLaren DJ
    Exp Parasitol; 1986 Oct; 62(2):223-36. PubMed ID: 3527740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of human complement.
    Marikovsky M; Levi-Schaffer F; Arnon R; Fishelson Z
    Exp Parasitol; 1986 Feb; 61(1):86-94. PubMed ID: 3943595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni: loss of the ability of schistosomula to bind mouse complement following intravenous injection into mice.
    Ruppel A; Rother U; Diesfeld HJ
    Tropenmed Parasitol; 1984 Mar; 35(1):23-8. PubMed ID: 6369693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni.
    Marikovsky M; Parizade M; Arnon R; Fishelson Z
    Eur J Immunol; 1990 Jan; 20(1):221-7. PubMed ID: 2307175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni: activation of the alternative pathway of human complement by schistosomula.
    Dias Da Silva W; Kasatchkine MD
    Exp Parasitol; 1980 Oct; 50(2):278-86. PubMed ID: 7409076
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
    Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
    Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro complement activation by intercellular antibodies.
    Hashimoto T; Sugiura M; Kurihara S; Nishikawa T
    J Invest Dermatol; 1982 Apr; 78(4):316-8. PubMed ID: 6978365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules.
    Dessein A; Samuelson JC; Butterworth AE; Hogan M; Sherry BA; Vadas MA; David JR
    Parasitology; 1981 Jun; 82(Pt 3):357-74. PubMed ID: 7243345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni: interactions of adult parasites with the complement system.
    Rasmussen KR; Kemp WM
    Parasite Immunol; 1987 Mar; 9(2):235-48. PubMed ID: 3574976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-mediated killing of schistosomula of Schistosoma mansoni by rat eosinophils in vitro.
    Ramalho-Pinto FJ; McLaren DJ; Smithers SR
    J Exp Med; 1978 Jan; 147(1):147-56. PubMed ID: 627834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
    Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
    Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cercarial glycocalyx of Schistosoma mansoni activates human complement.
    Samuelson JC; Caulfield JP
    Infect Immun; 1986 Jan; 51(1):181-6. PubMed ID: 3940995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 20. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.